Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 148

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 148
---
 manufacturing
facilities. We operate out of our offices in Herzliya 4676652, Israel that are being provided for a monthly fee of $5,500 (including
$3,000 for administrative expenses). We expect to lease additional space as we expand the team upon conclusion of this offering.

Legal Proceedings

CSL Behring GmbH Payment Dispute

In 2019, a controversy has
arisen between us and CSL whether certain unshipped minimum purchase commitments for fibrinogen from 2018 to 2020 are to be paid by us
pursuant to a Framework Supply Agreement dated March 8, 2016, or Framework Supply Agreement, by and between the Company and CSL, whereby
CSL agreed to supply the Company with fibrinogen. On January 14, 2020, we received a termination letter, or CSL Termination Letter. In
the CSL Termination Letter, CSL demanded a total amount of $820,000, claiming it was owed the minimum purchase commitment amounts under
the Framework Supply Agreement not paid by the Company in 2018 and 2019. In a subsequent correspondence, CSL additionally demanded interest
and damages for lost profit, with an aggregate demand amount of $1,476,382.36. The Company has disputed CSL’s payment demand and
contends that CSL’s demands are baseless under the Framework Supply Agreement, as the minimum purchase commitment under the Framework
Supply Agreement is conditional upon first obtaining approval of the FDA and the European Medicines Evaluation Agency, or EMEA, and other
quality and clinical milestones, none of which has occurred. Notwithstanding, CSL claimed to have obtained a valid German court order
in its favor and to endeavor to seek for its enforcement in Israel. In 2024, we initiated a proceeding in Germany to annul said German
court’s purported ruling. We submitted our arguments to the German court by way of a brief on April 11, 2025. In May 2025, the
German court issued a judgment dismissing our annulment claim. On July 4, 2025, we came to an agreement with CSL, or the CSL Settlement,
which would result in an immediate payment of $30,000 and a payment of $300,000 by us to CSL subsequent to the closing of this offering,
as well as reimbursement for certain of CSL’s legal expenses and two future payments of $300,000 and $200,000 by us to CSL upon
the achievement of certain